In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19Mahmoud Elkazzaz, Israa M. Shamkh, Amr Ahmed et al.|Vaccines|2022Cited by 17
Nontoxic and Naturally Occurring Active Compounds as Potential Inhibitors of Biological Targets in Liriomyza trifoliiIsraa M. Shamkh, Tomasz M. Karpiński, Ahmed Hassen Shntaif et al.|International Journal of Molecular Sciences|2022Cited by 8
<i>In-silico</i> Binding, Stability, Pharmacokinetics, and Toxicity Studies onNatural (-)-ambrox Metabolites as Binding Ligands to Luminal B andTriple-negative/basal-like Proteins for Breast Cancer TherapyAbdullah Haikal, Mohammed Albratty, Asim Najmi et al.|Letters in Drug Design & Discovery|2024Cited by 7
AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in HumansIsraa M. Shamkh, Amr Ahmed, Mahmoud Elkazzaz et al.|Current Pharmaceutical Design|2023Cited by 5
In silico Discovering STRA 6 Vitamin A Receptor, as a Novel Binding Receptor of COVID-19Mahmoud Elkazzaz, Israa M. Shamkh, Amr Ahmed et al.|Indian Journal of Pharmaceutical Education and Research|2023Cited by 3